Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11160826
Cholesterol lowering drugs for the treatment of hepatic encephalopathy
granted -
US 11160800
Methods of treatment using a JAK inhibitor compound
granted -
US 11160616
System and method of performing treatment along a lumen network
granted -
US 11154572
Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type
granted -
US 11147885
ASH1L inhibitors and methods of treatment therewith
granted -
US 11147844
Methods of treatment of infections using bacteria
granted -
US 11147631
System and method of performing treatment along a lumen network
granted -
US 11149047
Aryl imidazoles for treatment of cancer
granted -
US 11147790
Treatment of cutaneous disorders
granted -
US 11141400
Method of treatment
granted -
US 11141393
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 11142765
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted -
US 11136384
Methods for treatment of cancer comprising TIGIT-binding agents
granted -
US 11135225
Cancer treatments using combinations of CDK and ERK inhibitors
granted -
US 11129823
Combination treatment of ocular inflammatory disorders and diseases
granted -
US 11129810
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease
granted -
US 11129863
Composition, preparation method thereof, and application thereof in the prevention and treatment of mammary gland disease
granted -
US 11123295
Encholeated antifungal compounds for central nervous system delivery and treatment of Cryptococcus infections
granted -
US 11118180
Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
granted -
US 11116823
Treatment of α-galactosidase a deficiency
granted -
US 11118177
Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
granted -
US 11116740
Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome
granted -
US 11111238
Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer
granted -
US 11110177
ASH1L degraders and methods of treatment therewith
granted